History, Symptoms, and Management of Coats Disease

Early diagnosis and treatment improve outcomes.

By Jay K. Rathinavelu, BSE, Grant A. Justin, MD, Lejla Vajzovic, MD, FASRS

Clinical Pearls for Pediatric Retinal Detachment

Tailored treatment plans can improve outcomes.

By Seyyedehfatemeh Ghalibafan, MD, Louis Z. Cai, MD, Audina M. Berrocal, MD, et al.

Keeping Up With ICROP

Changes to retinopathy of prematurity classification impact practice.

By Brittni A. Scruggs, MD, PhD, Reeda Bou Said, MD

Vitreoretinal Adverse Effects Associated With Oxymetazoline Drops for Blepharoptosis

Alpha agonists may play a role in vitreoretinal traction.

By Jessica L. Barest, MD, Alan R. Dayan, MD

Detection of Peripheral Retinal Nonperfusion in Diabetic Patients Using Ultrawidefield Imaging

A panoramic view could shape treatment of diabetic retinal disease.

By Ali Erginay, MD

The Role of Multimodal Imaging in Geographic Atrophy Diagnosis and Monitoring

Now more than ever, it is imperative to diagnose patients with GA early.

By Mustafa Iftikhar, MD, Lejla Vajzovic, MD, FASRS

UPFRONT: New Treatments for Infant Retina Patients

By Peter K. Kaiser, MD

UVEITIS CORNER: A Year in Review for Uveitis

Read up on a selection of important studies.

By Sruthi Arepalli, MD

CODING Q&A: Billing for Technician Exams

Understand the rules regarding when you can bill separately for a technician exam.

By Kevin J. Corcoran, COE, CPC, CPMA, FNAO

NEW PRODUCT APPLICATIONS: Drug Slows the Progression of Geographic Atrophy

Clinical trials showed a significant rate of reduction in lesion growth after 12 months.

By Karen Appold, contributing writer

Clinical Trial Update November/December 2023

SUBSPECIALTY NEWS: Ryzumvi approved, positive gene therapy data, Syfovre receives J code, and more.

By Rochelle Nataloni, contributing writer